FREYR B2B Case Studies & Customer Successes

FREYR logo

Freyr is a Global Regulatory Solutions and Services company, focusing on the entire Regulatory value-chain ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions to post approval maintenance, Labeling, Artwork Change Management for Pharm...

Case Studies

Showing 38 FREYR Customer Success Stories

search button

American Multinational Pharmaceutical Company achieves swift MAH transfer and artwork updates with FREYR

a China-based biopharmaceutical company achieves smooth IND approval in China with FREYR regulatory support

China-based Biopharmaceutical Company logo

a China-based biopharmaceutical company achieves IND approval for its COVID-19 vaccine with FREYR regulatory support

China-based Biopharmaceutical Company logo

a China-based pharmaceutical company achieves successful FDA DMF submission with FREYR

a danish specialty pharmaceutical company achieves quality and compliance across 35 countries with FREYR end-to-end artwork support

a Dubai-based Healthcare Company achieves timely SFDA registration of Paclitaxel with FREYR

a Dutch-based biotechnology company achieves successful USDMF submission with FREYR

a France-based biopharmaceutical company achieves high-impact manuscript publication with FREYR

German Multinational Pharmaceutical and Life Sciences Company achieves successful OTC market switch in Brazil with FREYR

a German multinational pharmaceutical and life sciences company improves SaMD documentation consistency with FREYR

a German pharmaceutical company renews Mexico marketing authorization with Freyr LATAM

a global medical device manufacturer achieves rapid regulatory resource ramp-up with FREYR staff augmentation

an Indian multinational pharmaceutical giant achieves audit-ready integrated management processes with FREYR

an Innovative Medicines Company achieves regulatory compliance and market expansion with FREYR

Italian Multinational Pharmaceutical Company achieves successful FDA CARES Act 2023 submission with FREYR

a Japanese midsize global pharma and biotech company achieves 100% on-time submissions and 50% cost savings with Freyr

a Japanese pharmaceutical and biotechnology company accelerates global regulatory submissions with FREYR

a Korea-based Biotechnology Manufacturer Achieves Successful BLA Submission and LATAM/APAC Product Registration with FREYR

a leading biopharmaceutical company achieves submission-ready labeling compliance with FREYR

a leading Canada-based generic manufacturer achieves Health Canada labeling compliance with Freyr regulatory labeling support

a leading Canada-based pharmaceutical company achieves zero artwork recalls and significant cost savings with FREYR

a leading diagnostics manufacturer achieves IVDR compliance and 30% cost reduction with FREYR

a pharma giant clarifies FDA requirements for a complex generic injectable product with FREYR

a pharmaceutical company achieves first-cycle USFDA approval for a biosimilar with Freyr

a South Korea-based pharmaceutical company streamlines LATAM MAA submission for ENVLO with FREYR

a South Korea/China-based biopharma company achieves IND approval in China with FREYR’s sample test and regulatory support

a Switzerland-based biopharmaceutical company achieves timely BLA sample testing in China with Freyr regulatory operations support

a UK-based pharmaceutical company achieves successful USFDA-compliant ad-promo review with Freyr

a UK-based pharmaceutical company achieves 100% GMP compliance with FREYR's 2-week audit support

a US generic pharma company achieves regulatory compliance and efficient labeling support with FREYR

a US-based leading pharmaceutical manufacturer achieves seamless labeling transition for 1,500+ artworks with FREYR

a US-based multinational company achieves eCTD compliance in EAEU with FREYR

a US-based pharmaceutical company achieves seamless management of 70+ ANDAs and NDAs with FREYR

a US-based pharmaceutical manufacturer achieves 100% quality and on-time artwork updates for 1,500+ injectables with FREYR

a USA Pharmaceutical Company achieves compliant, error-free regulatory publishing in South Korea with FREYR

a USA-based biopharmaceutical company maintains IND status with Freyr

a US-based life sciences logistics firm achieves full GDP compliance with FREYR

a USA-based pharmaceutical consultant successfully submits YY201 IND with Freyr regulatory support

No matching case studies

Trivantis

24 Case Studies

Kinabase

3 Case Studies

Sofon

39 Case Studies